Regulation of human peripheral blood lymphocytes IL-10 BY SMS 201-995

[1]  E. Krenning,et al.  Somatostatin analogue scintigraphy in granulomatous diseases , 1994, European Journal of Nuclear Medicine.

[2]  G. Bismuth,et al.  Human CD5 promotes B-cell survival through stimulation of autocrine IL-10 production. , 2002, Blood.

[3]  D. lattuada,et al.  The apoptotic effect of somatostatin analogue SMS 201-995 on human lymphocytes , 2002, Journal of Neuroimmunology.

[4]  T. Stępień,et al.  Octreotide Inhibits the Secretion of Interleukin-12 from Mononuclear Cells in Human Peripheral Blood (PBMCs) In Vitro 1 , 2001, Hormone and metabolic research = Hormon- und Stoffwechselforschung = Hormones et metabolisme.

[5]  C. Akdis,et al.  Mechanisms of interleukin‐10‐mediated immune suppression , 2001, Immunology.

[6]  S. Lamberts,et al.  Somatostatin receptors in the haematopoietic system. , 2000, European journal of endocrinology.

[7]  L. Hofland,et al.  Somatostatin and somatostatin receptors in the immune system: a review. , 2000, European cytokine network.

[8]  K. Schulze-Osthoff,et al.  IL‐10 induces apoptosis in human monocytes involving the CD95 receptor/ligand pathway , 2000, European journal of immunology.

[9]  C. Akdis,et al.  IL‐10 directly acts on T cells by specifically altering the CD28 co‐stimulation pathway , 2000, European journal of immunology.

[10]  Robinson,et al.  The anti‐inflammatory effects of interleukin‐10 in allergic disease , 2000, Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology.

[11]  M. Pretolani.  Interleukin‐10: an anti‐inflammatory cytokine with therapeutic potential , 1999, Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology.

[12]  S. Gatti,et al.  Evidence that SMS 201-995 enhances the immunosuppressive effect of FK506. , 1998, International journal of immunopharmacology.

[13]  D. Elliott,et al.  Preprosomatostatin messenger RNA is expressed by inflammatory cells and induced by inflammatory mediators and cytokines. , 1998, Journal of immunology.

[14]  D. lattuada,et al.  Inhibitory effect of somatostatin on human T lymphocytes proliferation. , 1998, International journal of immunopharmacology.

[15]  A. Tsutsumi,et al.  Expression of somatostatin receptor subtype 2 mRNA in human lymphoid cells. , 1997, Cellular immunology.

[16]  G. Chrousos,et al.  Somatostatin may participate in the antiinflammatory actions of glucocorticoids. , 1995, Endocrinology.

[17]  T. Reisine,et al.  Molecular properties of somatostatin receptors , 1995, Neuroscience.

[18]  A. Iagnocco,et al.  Intra-articular somatostatin 14 reduces synovial thickness in rheumatoid arthritis: an ultrasonographic study. , 1995, International journal of clinical pharmacology research.

[19]  E. Krenning,et al.  The Presence of Somatostatin Receptors in Rheumatoid Arthritis , 1994 .

[20]  G. Chrousos,et al.  Somatostatin analogues suppress the inflammatory reaction in vivo. , 1994, The Journal of clinical investigation.

[21]  H. Bayhan,et al.  The Visualization of Granulomatous Disease With Somatostatin Receptor Scintigraphy , 1994, Clinical nuclear medicine.

[22]  E. Krenning,et al.  Somatostatin and the immune and haematopoetic system; a review , 1994, European journal of clinical investigation.

[23]  D. Elliott,et al.  Granuloma T lymphocytes in murine schistosomiasis mansoni have somatostatin receptors and respond to somatostatin with decreased IFN-gamma secretion. , 1992, Journal of immunology.

[24]  R. de Waal Malefyt,et al.  IL-10 is produced by subsets of human CD4+ T cell clones and peripheral blood T cells. , 1992, Journal of immunology.

[25]  T. Sumida,et al.  Somatostatin receptors on human lymphocytes and leukaemia cells. , 1990, Immunology.

[26]  G. Grasso,et al.  Somatostatin and vasoactive intestinal peptide reduce interferon gamma production by human peripheral blood mononuclear cells. , 1990, Immunobiology.

[27]  L. Wahl,et al.  Identification of Human Mononuclear Leukocytes Bearing Receptors for Somatostatin and Glucagon , 1981, Diabetes.

[28]  R. Guillemin,et al.  Somatostatin: physiological and clinical significance. , 1976, Annual review of medicine.